SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004752
Filing Date
2018-05-14
Accepted
2018-05-14 08:27:41
Documents
48
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20180331x10q.htm 10-Q 1484663
2 EX-10.1 rytm-20180331ex10127bda3.htm EX-10.1 643243
3 EX-10.2 rytm-20180331ex10259c880.htm EX-10.2 16474
4 EX-31.1 rytm-20180331ex311d02395.htm EX-31.1 15690
5 EX-31.2 rytm-20180331ex31228a3e2.htm EX-31.2 14868
6 EX-32.1 rytm-20180331ex32121d328.htm EX-32.1 8415
7 EX-32.2 rytm-20180331ex322ad7519.htm EX-32.2 8399
  Complete submission text file 0001558370-18-004752.txt   4923161

Data Files

Seq Description Document Type Size
8 EX-101.INS rytm-20180331.xml EX-101.INS 800322
9 EX-101.SCH rytm-20180331.xsd EX-101.SCH 26476
10 EX-101.CAL rytm-20180331_cal.xml EX-101.CAL 27750
11 EX-101.DEF rytm-20180331_def.xml EX-101.DEF 82540
12 EX-101.LAB rytm-20180331_lab.xml EX-101.LAB 244157
13 EX-101.PRE rytm-20180331_pre.xml EX-101.PRE 178860
Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 18828760
SIC: 2834 Pharmaceutical Preparations